Molecular Diagnostics
First Commercially Available Lab-Based Blood Test to Help Evaluate Concussion
Abbott Diagnostics has received U.S. Food and Drug Administration clearance for the first commercially available laboratory traumatic brain injury (TBI) blood test, making it widely available to hospitals in the U.S. More...08 Mar 2023
ApoB Protein Testing More Accurately Predicts Heart Disease Risk than Testing for Cholesterol Alone
Emerging data suggest that testing for levels of Apolipoprotein B-100 (ApoB), a protein responsible for transporting fat molecules including LDL cholesterol - notoriously known as the "bad cholesterol" - throughout the body, may be a more precise indicator of atherosclerotic cardiovascular disease. More...07 Mar 2023
Single Blood Test Detects Various Tumor Types Less Invasively Than Tissue Biopsy
Around 40% of childhood cancers are pediatric solid tumors. Although pediatric cancer is uncommon, children can develop various tumor types in different body parts, making differential diagnosis difficult. Now, a newly developed liquid biopsy for solid tumors could be highly beneficial in cases where surgery or a tissue biopsy is not possible, potentially enabling more targeted diagnoses. More...06 Mar 2023
Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy
Researchers have discovered that a genetic test, an established part of standard care in the UK and globally to predict patients' responses to other targeted cancer drugs, can also predict whether chemotherapy will work for bowel cancer patients. This discovery could aid in sparing patients from unnecessary toxicity and debilitating side effects by avoiding treatments that will not benefit them. More...06 Mar 2023
New Method to Detect RNA Viruses More Effective and Faster than PCR Test
A new innovative method to detect RNA viruses based on the triplex-forming probe technology paves the way for new options for detecting viruses such as SARS-CoV-2, the influenza A virus (H1N1) or the respiratory syncytial virus (RSV), a pathogen that affects newborn babies and needs careful differential diagnosis. More...01 Mar 2023
Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Clinical Chemistry System
P780
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
In Other News
Revolutionary Blood Test Enables Early Detection of Coronary Heart Disease
New Device That Detects Cancer Cells Could Help Avoid Invasive Biopsy Surgeries
Blood Test Could Diagnose Brain Cancer, Track Progression and Guide Treatment
AI Accurately Predicts Cardiovascular Disease by Examining Genes in DNA of Heart Patients
Novel Saliva Collection Device Keeps Analytes Stable at Ambient Temperatures for Weeks
New Ultrafast 5-Minute PCR Technology Faster Than Self-Diagnosis Kits
Blood Test to Measure Key Molecule Could Help Diagnose Vascular Dementia
Compact POCT Platform Unlocks Multiplexing Potential of Real-Time PCR
Portable Real-Time PCR System Resolves Problems of Limited Lab Space and Fragmented Samples
Simple Blood Tests for Signaling Proteins Could Predict Cancer or Inflammation
Recombinant ELISAs Increase Efficiency of CMV Serodiagnosis in Pregnant Women
Novel Esophageal Cancer Test Could Reduce Unnecessary Endoscopies
Non-Invasive Stool Test Could Diagnose Early Form of Parkinson’s Disease
Benchtop Multiplex Genetic Analyzer Helps Target, Identify, and Confirm Clinically Relevant Mutations
New Technique Designs Nucleic Acid Probes to Detect Rapidly Mutating Bacteria and Viruses
New Study to Help Identify Accurate microRNA Biomarkers for Early Detection and Treatment of Diabetes
D-Dimer Blood Test Detects Prosthetic Joint Infections as Accurately as Standard Tests
New Diagnostic Test 1,000 Times More Sensitive than Conventional Tests
Unique Biomarker Could Lead to Diagnostic Tests for Detection of Early-Stage Alzheimer’s
Voice-Activated Sample Pre-Treatment Device Enables Hands-Free, Safer DNA Handling
World’s First AI-Powered Diagnostic Test Accurately Identifies Respiratory Viruses in Five Minutes
New Blood Test Detects Prostate Cancer With 94% Accuracy
World’s First Comprehensive Risk Test for Breast & Ovarian Cancer Launched
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
